Analysis
US initial public offering proceeds have reached roughly $160.6 billion so far in 2026 as of August 19, according to Renaissance Capital data, putting the year within reach of 2021's full-year record of $175 billion with more than four months still to go -- and before accounting for Anthropic's own IPO, which the company is preparing to file as soon as the end of this month and hopes will match or exceed SpaceX's record size.
A record driven by both volume and mega-deals
232 companies have completed US IPOs so far this year, roughly 4% more than the same point in 2025 -- a real increase in deal count, not just a statistical artifact of a few outsized listings. But the dollar total is unusually concentrated: SpaceX's own June debut alone raised $86.2 billion including its overallotment option, meaning a single listing accounts for roughly half of the year's entire IPO proceeds total. That concentration matters for how durable this record pace actually is -- a market that hit $160.6 billion largely because of one company's mega-listing looks different, structurally, than one that reached the same total through broad-based demand across dozens of mid-sized deals.
What's still to come
Goldman Sachs had separately estimated roughly $160 billion in US IPO gross proceeds as a full-year target for 2026 -- a figure the market has essentially already reached with a third of the year still remaining. If Anthropic's IPO lands anywhere close to matching SpaceX's $86.2 billion size, 2026 wouldn't just approach the 2021 record, it would blow past it decisively, and OpenAI's own confidentially filed IPO -- still pending, with no set timeline -- represents additional unclaimed upside on top of that.
The rest of this year's pipeline includes a mix of company sizes far more typical of a normal IPO market than SpaceX's outlier scale -- Pulse has covered a run of defense and space listings this week alone:
- [Castelion](/pulse/castelion-13-billion-valuation-hypersonic-missiles-2026) -- $1B private round at a $13B valuation
- [Gravitics](/pulse/gravitics-125-million-nasdaq-ipo-space-stations-2026) -- $125M Nasdaq listing
Alongside a wave of biotech IPOs earlier in August that priced above range and popped on debut, that's evidence demand extends well beyond the handful of trillion-dollar AI-adjacent names dominating headlines.
The counterweight
2021's record was itself inflated by a historic wave of SPAC issuance that later proved to have overpriced many low-quality deals, and comparing 2026's proceeds total directly against that year risks treating two very different market structures as equivalent. A single mega-deal like SpaceX's contributing roughly half of 2026's total proceeds also means the record-pace narrative is more fragile than the headline number suggests: strip out SpaceX, and 2026's proceeds pace looks much closer to a solid-but-unremarkable year than a historic one, which is worth remembering before Anthropic's IPO gets credited with "breaking a record" that one company's listing effectively already defined the shape of.
